Rx Industry CEOs Are Taking “Positive” Steps On GMPs, FDA’s Galson Says

FDA's discussions with pharmaceutical industry CEOs over the past year give the agency confidence that manufacturing quality is improving, Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, told the Schwab Washington Research Group conference May 2